Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Drug Resistance

  Free Subscription


13.10.2025

1 Antimicrob Agents Chemother
6 Clin Infect Dis
3 Int J Antimicrob Agents
2 J Antimicrob Chemother
2 J Bacteriol
2 J Clin Microbiol
1 Nature
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. FRIAES A, Mamede R, Santos B, Marrao G, et al
    Increase of macrolide resistance among Streptococcus pyogenes pharyngitis driven by a mef(A)-msr(D)/emm2-ST55 lineage in Portugal (2014-2019).
    Antimicrob Agents Chemother. 2025 Oct 10:e0096825. doi: 10.1128/aac.00968.
    PubMed         Abstract available


    Clin Infect Dis

  2. HAO J, Liu X, Wang D, Hu H, et al
    Transmitted Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey.
    Clin Infect Dis. 2025 Apr 29:ciaf159. doi: 10.1093.
    PubMed         Abstract available

  3. ROGG L, Underwood M, Hanan N, Castillo-Mancilla JR, et al
    Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.
    Clin Infect Dis. 2025 Mar 21:ciaf135. doi: 10.1093.
    PubMed         Abstract available

  4. CHARPENTIER C, Berzow D, Le Hingrat Q, Kaiser R, et al
    HIV-2EU - Supporting Standardized HIV-2 Drug Resistance Interpretation: an Update.
    Clin Infect Dis. 2025 Mar 12:ciaf110. doi: 10.1093.
    PubMed         Abstract available

  5. DE MIGUEL R, de Lagarde Sebastian M, Blanco Arevalo JL, Pinto-Martinez A, et al
    Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical Trial.
    Clin Infect Dis. 2025 Mar 7:ciaf100. doi: 10.1093.
    PubMed         Abstract available

  6. CHEMALY RF, Shafat T, Wald A, Kotton CN, et al
    Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials.
    Clin Infect Dis. 2025 Jan 29:ciae638. doi: 10.1093.
    PubMed         Abstract available

  7. LEE YT, Chen SC
    Unveiling Latent Risk Patterns in Antimicrobial-Resistant Bacteremia: A Deeper Look at Pathogen-Specific Mortality.
    Clin Infect Dis. 2025 Oct 10:ciaf493. doi: 10.1093.
    PubMed        


    Int J Antimicrob Agents

  8. GAO S, Quan Y, Song S, Jin W, et al
    Corrigendum to "Disrupting bacterial metabolism by targeting LDH reverses Streptococcus suis aminoglycoside resistance" [International Journal of Antimicrobial Agents 66/6 (2025) 1-16/107599].
    Int J Antimicrob Agents. 2025 Oct 9:107631.
    PubMed        

  9. PATEL RR, Arun PP, Singh SK, Singh M, et al
    Overcoming Antimicrobial Resistance: Phage Therapy as a Promising Solution to Combat ESKAPE Pathogens.
    Int J Antimicrob Agents. 2025 Oct 8:107640.
    PubMed         Abstract available

  10. TAI JH, Lyu YY, Zhang YS, Chu WW, et al
    Global, Regional, and National Burden of Bacterial Carbapenem Resistance from 1990 to 2021 and Predictions up to 2035.
    Int J Antimicrob Agents. 2025 Oct 8:107636.
    PubMed         Abstract available


    J Antimicrob Chemother

  11. LAI CC, Liu CY, Huang KJ, Huang YT, et al
    Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
    J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
    PubMed         Abstract available

  12. CHOWDHURY FR, Findlay BL
    Sequential antibiotic exposure restores antibiotic susceptibility.
    J Antimicrob Chemother. 2025 Oct 8:dkaf350. doi: 10.1093.
    PubMed         Abstract available


    J Bacteriol

  13. ARYA G, Chodisetti PK, Espinosa J, Russo BC, et al
    Enterococcus faecium sagA mutants have cell envelope defects influencing antibiotic resistance and bacteriophage susceptibility.
    J Bacteriol. 2025 Oct 9:e0030225. doi: 10.1128/jb.00302.
    PubMed         Abstract available

  14. GJENNESTAD RS, Heggenhougen MV, Ruud Winther A, Moldstad J, et al
    The effect of MurM and a branched cell wall structure on penicillin resistance in Streptococcus pneumoniae.
    J Bacteriol. 2025 Oct 8:e0014125. doi: 10.1128/jb.00141.
    PubMed         Abstract available


    J Clin Microbiol

  15. YUKAWA K, Harada S, Komori K, Hayama B, et al
    Corynebacterium striatum infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission.
    J Clin Microbiol. 2025;63:e0082925.
    PubMed         Abstract available

  16. ARMSTRONG DT, Baird ECE, Pretty L, D'Agostino K, et al
    Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill the gap for fluoroquinolone testing?
    J Clin Microbiol. 2025;63:e0064325.
    PubMed         Abstract available


    Nature

  17. KAVANAGH K
    The rise of 'nightmare bacteria': antimicrobial resistance in five charts.
    Nature. 2025 Oct 7. doi: 10.1038/d41586-025-03218.
    PubMed        


    PLoS One

  18. GOBEZIE MY, Hassen M, Solomon T, Demessie MB, et al
    Carriage rates and antimicrobial resistance of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0333054.
    PubMed         Abstract available

  19. SHRESTHA P, Tandukar S, Shrestha M, Shrestha S, et al
    Bacteriophage as an anti-biofilm agent against Pseudomonas aeruginosa from wound infection.
    PLoS One. 2025;20:e0334139.
    PubMed         Abstract available

  20. BRUINS MJ, Eijkelkamp-Biesterbos L, Meutstege AM, Dos Santos CO, et al
    Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database.
    PLoS One. 2025;20:e0334222.
    PubMed         Abstract available

  21. CUMMINGS CL, Landreville KD, Kuzma J
    Public perceptions and support for introduced microbes to combat hospital-acquired infections and antimicrobial resistance.
    PLoS One. 2025;20:e0332578.
    PubMed         Abstract available

  22. MENGISTU AB, Belete MA, Tassew H, Kassa HY, et al
    Multidrug-resistant non-typhoidal Salmonella enterica from chickens, farmworkers, and environments: One health implications from Northwestern Ethiopia.
    PLoS One. 2025;20:e0333591.
    PubMed         Abstract available

  23. YOSEF HL, Yohannes M, Diriba R, Legese MH, et al
    Multidrug-resistant bacterial profiles of inanimate objects at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0333361.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.